690P Ifinatamab deruxtecan (I-DXd; DS-7300) in patients with advanced solid tumors: Updated clinical and biomarker results from a phase I/II study

Manish R. Patel, Toshihiko Doi, T. Koyama, Gerald S. Falchook, Claire F. Friedman, Sarina A. Piha‐Paul, Martin Gutierrez, Mark M. Awad, Ahmad Mattour, Toshihiko Satoh, Norihiro Okamoto, Jasveer Singh, N. Yoshizuka, Meng Qian, Xiaozhong Qian, Brittany P. Tran, O. Dosunmu, Lu Wang, Melissa L. Johnson